aortic insufficiency (AI)
Jump to navigation
Jump to search
Introduction
Insufficiency of the aortic valve during diastole.
Classification
- mild
- vena contracta width < 0.3 cm
- regurgitant oriface area < 0.10 cm2
- regurgitant volume < 30 mL
- normal LV ejection fraction
- moderate
- vena contracta width 0.3-0.6 cm
- regurgitant oriface area 0.10-0.29 cm2
- regurgitant volume 30-59 mL
- regurgitant fraction 30-49%
- severe
- vena contracta width > 0.6 cm
- regurgitant oriface area >= 0.30 cm2
- regurgitant volume >= 60 mL
- regurgitant fraction > 50%
Etiology
- abnormality in the aortic valve
- dilation & distortion of the aortic root
- systemic hypertension
- ascending aortic dissection*
- syphilis (uncommon)
- cystic medionecrosis
- Marfan's syndrome
- ankylosing spondylitis
- osteogenesis imperfecta
- aneurysm of Valsalva sinus
* most common causes of acute aortic insufficiency
Pathology
- chronic AI
- acute AI
- marked increase in LVEDP
- time course too acute for compensatory mechanisms
Clinical manifestations
- acute AI
- severe heart failure
- cardiogenic shock
- pulmonary edema, inspiratory crackles
- tachycardia
- diastolic murmur
- short, soft, sometimes inaudible at the cardiac base & mid stermum[15]
- may be masked by tachycardia[5]
- soft S1, S3
- atrial gallop
- normal pulse pressure
- Traube's sign, de Musset's sign, Duroziez murmur present in chronic AI absent in acute AI
- chronic AI usually presents insidiously
- angina pectoris
- dyspnea on exertion
- orthopnea
- wide pulse pressure (chronic but not acute AI)
- diastolic murmur
- high-pitched decrescendo
- radiation along left sternal border (aortic leaflets) or right sternal border (aortic root)
- accentuated by leaning forward & exhalation
- a low-pitched rumbling diastolic murmur may occur (Austin-Flint murmur)[5]
- murmur does not radiate[5]
- severity of AI difficult to determine by auscultation
- rapid forceful carotid upstroke with marked collapse
- bounding carotid pulse (Corrigan's pulse)
- bounding peripheral pulse[5]
- head bobbing with each systole (de Musset's sign)
- prominent pulsations of skin capillaries (Quincke's pulse)
- popliteal artery pressure > brachial artery pressure (Hill's sign)
- murmur heard over the femoral artery (Duroziez murmur)
- 'pistol shot' sound over peripheral arteries (Traube's sign)
- displaced & hyperdynamic point of maximum impulse (PMI)
- enlarged, displaced apical impulse[5]
- soft S1, loud S3 or S4, soft or absent A2
- paradoxical splitting of S2 may occur
- dyspnea or fatigue with left ventricular failure
- signs of chronic volume overload (congestive heart failure)
Laboratory
Diagnostic procedures
- electrocardiogram:
- may show left ventricular hypertrophy
- left axis deviation
- conduction abnormalities suggest aortic root pathology
- prolongation of PR interval suggests endocarditis that has extended into the aortic valve annulus
- echocardiography - Doppler
- early mitral valve closure (acute AI)
- diastolic flow reversal
- presence & severity of AI
- LV size & function
- aortic root size
- frequency of serial evaluation
- every 5 years for asymptomatic patients with mild AI (regurgitant fraction < 30%)[12]
- every 1-2 years for asymptomatic patients with moderate AI (regurgitant fraction 30-50%)[5][12]
- every 6-12 months for asymptomatic patients with severe AI (regurgitant fraction >50%)[5]
- cardiac catheterization
Radiology
- chest X-ray
- cardiomegaly in chronic cases, normal with acute AI
- pulmonary vascular congestion
- aortic root dilatation
- calcification of aortic root
- double lumen sign when aortic dissection is present
- radionuclide ventriculography
- computed tomography if suspecting aortic dissection
Differential diagnosis
- consider aortic dissection
- ruptured sinus of Valsalva
Management
- stabilization of patients with acute AI before surgery
- nitroprusside
- inotropic agents
- dobutamine
- amrionone, milrinone
- avoid beta-blockers[5] d avoid intra-aortic balloon pump[5]
- chronic, stable AI
- treatment of underlying causes
- prophylaxis for endocarditis[5];
- no longer recommended[7]
- left ventricular dysfunction
- restriction of strenuous physical activity
- isometric exercise (i.e. weight-lifting) more detrimental than walking or swimming
- fluid & salt restriction
- diuretics
- digoxin
- afterload reduction (hypertension)
- ACE inhibitor or ARB[5][10]
- dihydropyridine calcium channel blocker[5]
- vasodilators (nifedipine or enalapril) of no benefit in delaying surgery[6]
- restriction of strenuous physical activity
- surgery
- acute AI: aortic valve replacement
- immediate aortic valve replacement (AVR)
- repair of associated aortic root abnormalities (aortic dissection)
- infective endocarditis - delay surgery for several days of antibiotics if patient can be medically stabilized
- Ross procedure
- chronic AI: aortic valve replacement
- signs & symptoms of moderate heart failure (New York Heart Association class II-III), exercise intolerance
- left ventricular dysfunction[5]
- LVEF < 50-55%, progressive LV dilation[5]
- reversibility of LV dysfunction depends upon:
- duration of dysfunction
- dilatation of left ventricle; LV end-systolic dimension > 5.0 cm[5]
- degree of systolic dysfunction
- asymptomatic severe AI with LVEF < 50-55% & progressive LV dilation are at increased risk for heart failure & sudden death[5]
- symptomatic severe AI regardless of LVEF[5]
- transcatheter aortic valve replacement (TAVR) may be an option
- in-hospital mortality similar with TAVR or surgical aortic valve replacement[13]
- moderate or severe aortic insufficiency if patient undergoes other cardiad surgery (CABG, mitral valve repair)
- acute AI: aortic valve replacement
- follow-up (no indication for aortic valve replacement, yet)
- clinical evaluation yearly
- every 6 months if LV dilation or severe disease
- echocardiogram (patient asymptomatic)
- clinical evaluation yearly
Additional terms
References
- ↑ Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 129-30
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 260-61
- ↑ DeGowin & DeGowin's Diagnostic Examination, 6th edition, RL DeGowin (ed), McGraw Hill, NY 1994, pg 865-66
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 41-42
- ↑ 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 16, 17, 18. American College of Physicians, Philadelphia 1998, 2006, 2012, 2015, 2018.
Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022 - ↑ 6.0 6.1 Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, Soler-Soler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med. 2005 Sep 29;353(13):1342-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16192479
Carabello BA. Vasodilators in aortic regurgitation--where is the evidence of their effectiveness? N Engl J Med. 2005 Sep 29;353(13):1400-2. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16192487 - ↑ 7.0 7.1 Wilson W et al, Prevention of infective endocardititis: guidelines from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committe, Council on Cardiovascular Disease in the Young, and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J AM Dent Assoc 2008, 139:3S PMID: https://www.ncbi.nlm.nih.gov/pubmed/18167394
- ↑ Choudhry NK, Etchells EE. The rational clinical examination. Does this patient have aortic regurgitation? JAMA. 1999 Jun 16;281(23):2231-8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/10376577
- ↑ Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation 2005 Jul 7; 112:125 PMID: https://www.ncbi.nlm.nih.gov/pubmed/15998697 Free full text
- ↑ 10.0 10.1 Elder DH, Wei L, Szwejkowski BR et al The impact of renin-angiotensin-aldosterone system blockade on heart failure outcomes and mortality in patients identified to have aortic regurgitation: a large population cohort study. J Am Coll Cardiol. 2011 Nov 8;58(20):2084-91 PMID: https://www.ncbi.nlm.nih.gov/pubmed/22051330 Free full text
- ↑ Enriquez-Sarano M, Tajik AJ Clinical practice. Aortic regurgitation. N Engl J Med. 2004 Oct 7;351(15):1539-46. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15470217
- ↑ 12.0 12.1 12.2 Yang LT, Enriquez-Sarano M, Michelena HI et al. Predictors of progression in patients with stage B aortic regurgitation. J Am Coll Cardiol 2019 Nov 19; 74:2480-2492. PMID: https://www.ncbi.nlm.nih.gov/pubmed/31727286
- ↑ 13.0 13.1 Alharbi AA et al. Transcatheter aortic valve replacement vs surgical replacement in patients with pure aortic insufficiency. Mayo Clin Proc 2020 Dec; 95:265 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33276838 https://www.mayoclinicproceedings.org/article/S0025-6196(20)30853-3/fulltext
- ↑ 14.0 14.1 Akinseye OA, Pathak A, Ibebuogu UN. Aortic valve regurgitation: A comprehensive review. Curr Probl Cardiol. 2018;43:315-334. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29174586
- ↑ 15.0 15.1 NEJM Knowledge+